Biomarin Pharmaceutical Inc (BMRN)
65.69
+0.69
(+1.06%)
USD |
NASDAQ |
Dec 20, 16:00
65.65
-0.04
(-0.06%)
After-Hours: 20:00
Biomarin Pharmaceutical Price: 65.69 for Dec. 20, 2024
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co Inc | 98.05 |
| Biogen Inc | 146.47 |
| Pfizer Inc | 26.36 |
| Bristol-Myers Squibb Co | 57.33 |
| Moderna Inc | 39.39 |
Price Related Metrics
| PE Ratio | 39.34 |
| PS Ratio | 4.686 |
| PEG Ratio | 0.3355 |
| Price to Book Value | 2.313 |
| Price to Free Cash Flow | 42.87 |
| Earnings Yield | 2.54% |
| Market Cap | 12.52B |
| PEGY Ratio | 0.3355 |
| Operating PE Ratio | 41.29 |
| Normalized PE Ratio | 40.35 |